| β-catenin activation promotes immune escape and resistance to anti–PD-1 therapy in hepatocellular carcinoma M Ruiz de Galarreta, E Bresnahan, P Molina-Sánchez, KE Lindblad, ... Cancer discovery 9 (8), 1124-1141, 2019 | 609 | 2019 |
| Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002–2020) PK Haber, M Puigvehí, F Castet, V Lourdusamy, R Montal, P Tabrizian, ... Gastroenterology 161 (3), 879-898, 2021 | 157 | 2021 |
| Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification C Montironi, F Castet, PK Haber, R Pinyol, M Torres-Martin, L Torrens, ... Gut 72 (1), 129-140, 2023 | 125 | 2023 |
| Immunomodulatory effects of lenvatinib plus anti–programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular carcinoma L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology 74 (5), 2652-2669, 2021 | 98 | 2021 |
| Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma PK Haber, F Castet, M Torres-Martin, C Andreu-Oller, M Puigvehí, M Miho, ... Gastroenterology 164 (1), 72-88. e18, 2023 | 82 | 2023 |
| The oncogenic role of hepatitis delta virus in hepatocellular carcinoma M Puigvehí, C Moctezuma-Velázquez, A Villanueva, JM Llovet JHEP Reports 1 (2), 120-130, 2019 | 60 | 2019 |
| Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients M Puigvehí, T Broquetas, S Coll, M Garcia‐Retortillo, N Cañete, ... Journal of Gastroenterology and Hepatology 32 (10), 1746-1753, 2017 | 44 | 2017 |
| Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades M Puigvehí, D Hashim, PK Haber, A Dinani, TD Schiano, A Asgharpour, ... American Journal of Transplantation 20 (1), 220-230, 2020 | 38 | 2020 |
| Impact of age-and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening C Alvarez-Urturi, M Andreu, C Hernandez, F Perez-Riquelme, F Carballo, ... Digestive and Liver Disease 48 (5), 542-551, 2016 | 35 | 2016 |
| Solitary cavernous hemangioma of the small intestine as the cause of long-standing iron deficiency anemia M Pera, L Márquez, JM Dedeu, J Sánchez, M Garcia, JM Ramón, ... Journal of Gastrointestinal Surgery 16, 2288-2290, 2012 | 32 | 2012 |
| Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators JA Carrion, M Puigvehi, S Coll, M Garcia‐Retortillo, N Canete, ... Journal of Viral Hepatitis 22 (3), 297-306, 2015 | 31 | 2015 |
| Outcome in obscure gastrointestinal bleeding after capsule endoscopy A Cañas-Ventura, L Márquez, X Bessa, JM Dedeu, M Puigvehí, ... World Journal of Gastrointestinal Endoscopy 5 (11), 551, 2013 | 28 | 2013 |
| Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV–cirrhotic patients M Puigvehí, MC Londoño, X Torras, S Lorente, M Vergara, RM Morillas, ... Journal of Gastroenterology 55, 205-216, 2020 | 25 | 2020 |
| Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos (t) ide analogues T Broquetas, M Garcia-Retortillo, JJ Hernandez, M Puigvehí, N Canete, ... PloS one 12 (11), e0188303, 2017 | 21 | 2017 |
| β-catenin activation promotes immune escape and resistance to anti–PD-1 therapy in hepatocellular carcinoma. Cancer Discov. 2019; 9: 1124–1141. doi: 10.1158/2159-8290 MR De Galarreta, E Bresnahan, P Molina-Sánchez, KE Lindblad, B Maier, ... CD-19-0074.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 20 | |
| Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C S Lens, F Torres, M Puigvehi, Z Marino, MC Londoño, SM Martinez, ... Alimentary Pharmacology & Therapeutics 43 (3), 364-374, 2016 | 19 | 2016 |
| Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma. L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology, 2021, vol. 74, num. 5, p. 2652-2669, 2021 | 15 | 2021 |
| Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years M Puigvehí, J Hernández, T Broquetas, S Coll, M Garcia-Retortillo, ... PLoS One 11 (12), e0164883, 2016 | 14 | 2016 |
| Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos (t) ids analogues in hepatitis B e antigen-negative patients T Broquetas, M Garcia-Retortillo, M Micó, L Canillas, M Puigvehí, ... World Journal of Hepatology 12 (11), 1076, 2020 | 11 | 2020 |
| On-therapy HBsAg kinetics can predict HBsAg loss after nucleos (t) ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty T Broquetas, JJ Hernandez, M Garcia-Retortillo, L Canillas, M Puigvehí, ... Digestive and Liver Disease 54 (8), 1044-1051, 2022 | 10 | 2022 |
